Yan Ma

2.7k total citations
67 papers, 1.6k citations indexed

About

Yan Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yan Ma has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Yan Ma's work include Sarcoma Diagnosis and Treatment (15 papers), Cancer-related Molecular Pathways (9 papers) and Effects of Radiation Exposure (7 papers). Yan Ma is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Cancer-related Molecular Pathways (9 papers) and Effects of Radiation Exposure (7 papers). Yan Ma collaborates with scholars based in United States, China and Canada. Yan Ma's co-authors include David G. Kirsch, Chang‐Lung Lee, Everett J. Moding, Diana M. Cardona, Lixia Luo, Rebecca D. Dodd, Cristian T. Badea, Jeffrey K. Mito, Mohit Sachdeva and Yi Qi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Ma

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ma United States 25 771 422 389 353 283 67 1.6k
Kathleen C. Day United States 20 873 1.1× 254 0.6× 289 0.7× 506 1.4× 464 1.6× 37 1.9k
Madeleine M. Handsley United Kingdom 8 772 1.0× 525 1.2× 223 0.6× 591 1.7× 248 0.9× 9 1.8k
Michael J. Flister United States 22 758 1.0× 230 0.5× 161 0.4× 599 1.7× 152 0.5× 53 1.6k
Fotini M. Kouri United States 16 992 1.3× 356 0.8× 385 1.0× 105 0.3× 206 0.7× 16 1.6k
Ronald J. Bernardi United States 13 673 0.9× 168 0.4× 137 0.4× 291 0.8× 111 0.4× 14 1.3k
Chunhui Di United States 18 1.2k 1.5× 353 0.8× 191 0.5× 440 1.2× 110 0.4× 26 2.0k
Tracy Criswell United States 23 1.1k 1.4× 279 0.7× 200 0.5× 644 1.8× 255 0.9× 52 2.0k
Róisín M. Dwyer Ireland 31 1.8k 2.4× 1.2k 2.9× 175 0.4× 829 2.3× 332 1.2× 68 3.2k
Austin K. Mattox United States 13 461 0.6× 280 0.7× 159 0.4× 209 0.6× 107 0.4× 27 1.1k

Countries citing papers authored by Yan Ma

Since Specialization
Citations

This map shows the geographic impact of Yan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ma more than expected).

Fields of papers citing papers by Yan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ma. The network helps show where Yan Ma may publish in the future.

Co-authorship network of co-authors of Yan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ma. A scholar is included among the top collaborators of Yan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ma. Yan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Rutulkumar, Lixia Luo, Yan Ma, et al.. (2025). Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 31(19). 4184–4195.
2.
Wisdom, Amy J., Lixia Luo, Yan Ma, et al.. (2025). Loss of function of Atrx recapitulates phenotypes of alternative lengthening of telomeres in a primary mouse model of sarcoma. iScience. 28(5). 112357–112357. 1 indexed citations
3.
Hendrickson, Peter G., Lixia Luo, Yan Ma, et al.. (2024). Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice. Oncogene. 43(16). 1223–1230. 4 indexed citations
4.
Su, Chang, Rutulkumar Patel, Lixia Luo, et al.. (2023). Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus. Journal of Clinical Investigation. 133(13). 12 indexed citations
5.
Patel, Rutulkumar, Yvonne M. Mowery, Yi Qi, et al.. (2022). Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma. Molecular Cancer Therapeutics. 22(1). 112–122. 4 indexed citations
6.
Lee, Chang‐Lung, Andrea R. Daniel, Matt Holbrook, et al.. (2021). Characterization of cardiovascular injury in mice following partial-heart irradiation with clinically relevant dose and fractionation. Radiotherapy and Oncology. 157. 155–162. 12 indexed citations
7.
Li, Ji, Yan Ma, Xiaohui Miao, Jidong Guo, & Da‐Wei Li. (2021). Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke. Neurological Sciences. 42(9). 3585–3593. 30 indexed citations
8.
Crabtree, Donna, Nerissa T. Williams, Lixia Luo, et al.. (2021). Radiosensitizing the Vasculature of Primary Brainstem Gliomas Fails to Improve Tumor Response to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 112(3). 771–779. 6 indexed citations
9.
Dodd, Rebecca D., Wesley Huang, Wade R. Gutierrez, et al.. (2020). Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten -deleted Mouse Models of Sarcoma. Clinical Cancer Research. 26(18). 5036–5047. 7 indexed citations
10.
Crabtree, Donna, Nerissa T. Williams, Lixia Luo, et al.. (2020). Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models. Journal of Clinical Investigation. 131(1). 26 indexed citations
11.
Chen, Mark, Eric S. Xu, Diana M. Cardona, et al.. (2019). The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice. Sarcoma. 2019. 1–14. 9 indexed citations
12.
Huang, Jianguo, Mark Chen, Eric S. Xu, et al.. (2019). Genome-wide CRISPR Screen to Identify Genes that Suppress Transformation in the Presence of Endogenous KrasG12D. Scientific Reports. 9(1). 17220–17220. 5 indexed citations
13.
Torok, Jordan A., Katherine D. Castle, Yan Ma, et al.. (2018). Deletion of Atm in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung Adenocarcinoma. Cancer Research. 79(4). 773–782. 25 indexed citations
14.
Wisdom, Amy J., Katherine D. Castle, Yvonne M. Mowery, et al.. (2018). Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma. Molecular Cancer Therapeutics. 17(4). 858–868. 23 indexed citations
15.
Mater, David Van, Eric S. Xu, Anupama Reddy, et al.. (2018). Injury promotes sarcoma development in a genetically and temporally restricted manner. JCI Insight. 3(20). 10 indexed citations
16.
Dodd, Rebecca D., Chang‐Lung Lee, Wesley Huang, et al.. (2017). NF1+/− Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response. Cancer Research. 77(16). 4486–4497. 21 indexed citations
17.
Mater, David Van, Jordan M. Blum, Micah T. Webster, et al.. (2014). Acute Tissue Injury Activates Satellite Cells and Promotes Sarcoma Formation via the HGF/c-MET Signaling Pathway. Cancer Research. 75(3). 605–614. 24 indexed citations
18.
Sachdeva, Mohit, Jeffrey K. Mito, Chang‐Lung Lee, et al.. (2014). MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. Journal of Clinical Investigation. 124(10). 4305–4319. 84 indexed citations
19.
Dodd, Rebecca D., Jeffrey K. Mito, William C. Eward, et al.. (2013). NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition. Molecular Cancer Therapeutics. 12(9). 1906–1917. 62 indexed citations
20.
Li, Zhizhong, Yunyu Zhang, Krishnan Ramanujan, et al.. (2013). Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2–IGF2BP2 Pathway. Cancer Research. 73(10). 3041–3050. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen C. Day Breakdown of academic impact, for papers by Madeleine M. Handsley Breakdown of academic impact, for papers by Michael J. Flister Breakdown of academic impact, for papers by Fotini M. Kouri Breakdown of academic impact, for papers by Ronald J. Bernardi Breakdown of academic impact, for papers by Chunhui Di Breakdown of academic impact, for papers by Tracy Criswell Breakdown of academic impact, for papers by Róisín M. Dwyer Breakdown of academic impact, for papers by Austin K. Mattox
Rankless by CCL
2026